Trial Information

Summary: Vascular dementia study

Patients with dementia due to vascular disease in the brain will be studied to test the effects of a new investigational drug treatment. Patients must be between the ages of 50 and 85, have a diagnosis of vascular dementia, be in generally good health, and have a caregiver who will participate in the study with them.

Each patient in the study will be randomly assigned to receive either the new drug treatment or placebo and will be followed for 6 months. There are a total of 7 visits to the clinic. Patients and their caregivers will answer questions and take tests to measure change in memory, other cognitive functions, activities of daily living, quality of life, and psychological symptoms.

Patients who participate in this study will receive without charge:

• Full diagnostic evaluation including MRI scan
• Investigational study medication
• EKG, laboratory tests, and physical examinations

Patients who complete the study will be eligible to receive open-label treatment with the new drug treatment for up to a year.

If you would like to learn more about participating in this study, please send an e-mail message using the form below.